Our team are attending BioTrinity in London from 25th to 26th April, meeting with investors and pharma/biotech partners from across the life science industry.
Dr Sheelagh Frame, our CSO, will be discussing the opportunities for harnessing DUBs for targeted protein stabilisation and beyond, as well as sharing insights into her career, the opportunities and challenges for women in life sciences, and the changes she would like to see within the industry:
- 26th April, 11:45-12:15 – Technical Update: Harnessing DUBs for targeted protein stabilisation and beyond
- 26th April, 13:30-14:30 - Panel: Inspiring Women in Science
If you would like to schedule a meeting, get in touch via the partneringONE platform or contact us directly here.